Office Locations:

HARRISBURG OFFICE:
1300 Linglestown Rd.
Harrisburg, PA 17110
Tel: (717) 238-2000
Fax: (717) 233-3029

LANCASTER OFFICE:
2148 Embassy Dr.
Suite 107
Lancaster, PA 17603
Tel: (717) 431-4000
Fax: (717) 233-3029

 

CARLISLE OFFICE:
26 State Avenue
Suite 103
Carlisle, PA 17013
Tel: (717) 241-2244
Fax: (717) 233-3029

 

HANOVER OFFICE: 
217 Frederick St.
Hanover, PA 17331
Tel: (717) 630-8200
Fax: (717) 233-3029

 

YORK OFFICE:
2550 Kingston Rd.
Suite 220
York, PA 17402
Tel: (717) 845-7800
Fax: (717) 233-3029

 

The Food and Drug Administration (FDA) is issuing a Safety Alert on Avandia (Rosiglitazone). This drug was approved in 1999 for the treatment of type 2 diabetes. Diabetes is a serious and life threatening disease that is the leading cause of coronary heart disease and affects up to 20 million Americans.

Patients taking Avandia may have a 30-40 percent increased risk of heart attack and/or other heart-related affects, including death. Those patients who know to have heart disease or who are at high risk of heart attack, should consult with their doctor to evaluate their treatment options

What is Avandia?

Avandia (Rosiglitazone) is a drug that was approved and widely used to help treat patients with type 2 diabetes. It helps improve the control of blood sugar by increasing the body's sensitivity to insulin, but some side effects may cause patients risk of heart failure and/or other heart realted problems.

60,000 - 100,000 heart attacks might be linked to Avandia since it came out eight years ago.

According to an article published in the New England Journal of Medicine, "Rosiglitazone was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes that had borderline significance".

If you or someone you love has or is taking Avanadia medication and is either experiencing unusual side effects or would like more information on your legal rights and options, please contact the Law Offices of Handler, Henning & Rosenberg at 1-800-422-2224.

Increased Risk of Heart Attack

Ever since Avandia was approved in 1999, the FDA has been running controlled clinical tests in order to determine other potential heart-related risks with Avandia. Some recent data is showing that patients using Avandia to help treat type 2 diabetes have a 30-40 percent increased risk of heart attack and other heart-related problems than patients who treat their diabetes with placebo or other anti-diabetic therapy.

More than 6 million people have been treating their type 2 diabetes with Avandia or Avandamet (related drug) since it came on the market in 1999.

Click Here for more information from www.fda.gov

Contact Handler, Henning & Rosenberg, LLP at 1-800-422-2224 for a FREE Consulattion and more information regarding Avandia.

Auto Accidents •  Workers' Compensation • Birth Injuries • Medical Malpractice • Cerebral Palsy • Guidant Heart Defibrillators
Asbestos and Mesothelioma • Ortho Evra • Trucking Accidents • Social Security Disability • Dog Bite Injuries • Ketek • Trasylol
Complete Moisture Plus™ Contact Lens Solution • Orthopedic Pain Patch

The information you obtain at this site is not, nor is it intended to be, legal advice. Copyright © 2007 by Handler, Henning & Rosenberg, LLP.
All rights reserved. You may reproduce materials available at this site for your own personal use and for
non-commercial distribution. All copies must include this copyright statement.

Site Designed & Hosted by EMC Advertising